Lung Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient is 18-75 years old, and voluntarily cooperates with the questionnaire survey; 2. ECOG score 0-2; 3. The expected life is not less than 6 months; 4. Patients with non-small cell lung cancer diagnosed by pathology (histology or cytology) after surgery (classified according to WHO in 2015) who are highly suspicious of lung cancer according to chest imaging examination and plan to undergo surgical treatment; 5. Those who have not undergone radiotherapy, chemotherapy, surgery and targeted treatment before enrollment; 6. The subject must have sufficient cardiopulmonary function for the intended pneumonectomy; 7. Main organs function normally 8. Subjects volunteered to join the study and signed the informed consent procedure, with good compliance and cooperation in follow-up.
Exclusion criteria
Exclusion criteria: 1. The patients have no ability to read and understand the survey items of the scale; 2. Symptomatic central nervous system metastasis; 3. Other malignant tumors in the past 3 years; 4. According to the true judgment of the study, there are concomitant diseases that may confuse the study results or affect the completion of the study 5. Subjects who are participating in other clinical studies or whose enrollment time is less than 4 weeks from the end of the previous clinical study (the last medication or follow-up), or who have 5 half lives of the study drug; 6. Subjects are known to have a history of abuse of psychotropic substances, alcohol abuse or drug abuse; 7. The investigator believes that there are any circumstances that may damage the subject or cause the subject to be unable to meet or perform the research requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The threshold number and comprehensive score of the target symptom; | — |
Secondary
| Measure | Time frame |
|---|---|
| Andson symptom assessment scale, Chinese version, functional score;Doctor Satisfaction;Patient satisfaction;Incidence of complications;EORTC QLQ-C30 (version 3)&LC13; | — |
Countries
China
Contacts
Tangdu Hospital of the Fourth Military Medical University